Statin Use in ICH Linked to Lower Risk for Subsequent Stroke

Observational data suggest that use of statins after intracerebral hemorrhage is linked to lower risk for recurrent stroke. Researchers call for a randomized trial of statins in these patients.

Related Keywords

United States , New York , Odense , Syddanmark , Denmark , Boston , Massachusetts , American , Danish , Magdy Selim , Christopher Kellner , David Gaist , Harvard Medical School , American Academy Of Neurology , Intracerebral Hemorrhage Program , National Institute Of Neurological Disorders , Icahn School Of Medicine At Mount Sinai , University Of Southern Denmark , American Academy , Southern Denmark , Medscape Medical , Stroke Prevention , Aggressive Reduction , Cholesterol Levels , Danish Stroke Registry , Medscape Medical News , Icahn School , Mount Sinai , New York City , National Institute , Neurological Disorders , Beth Israel Deaconess Hospital , Principal Investigator , Stroke , Erebrovascular Accident , Va Cerebrovascular Accident , Cerebrovascular Disease , Stroke Risk , Ischemic Stroke , Intracranial Hemorrhage , Intracranial Bleeding , Hemorrhagic Stroke , Intracerebral Hemmorhage , Brain , Lipids , Ipid Management , Statin , Lipid Lowering Drugs , Rug Lipid Lowering , Clinical Research , Clinical Trials , Linical Studies ,